AGL 23.81 Decreased By ▼ -0.54 (-2.22%)
AIRLINK 103.60 Increased By ▲ 0.60 (0.58%)
BOP 5.66 Decreased By ▼ -0.05 (-0.88%)
CNERGY 3.93 Decreased By ▼ -0.03 (-0.76%)
DCL 8.36 Decreased By ▼ -0.14 (-1.65%)
DFML 41.70 Decreased By ▼ -1.29 (-3%)
DGKC 88.30 Decreased By ▼ -0.60 (-0.67%)
FCCL 22.70 No Change ▼ 0.00 (0%)
FFBL 40.88 Increased By ▲ 2.68 (7.02%)
FFL 8.96 Decreased By ▼ -0.15 (-1.65%)
HUBC 160.49 Decreased By ▼ -3.21 (-1.96%)
HUMNL 11.46 Decreased By ▼ -0.34 (-2.88%)
KEL 4.82 Decreased By ▼ -0.03 (-0.62%)
KOSM 4.09 Decreased By ▼ -0.04 (-0.97%)
MLCF 38.60 Increased By ▲ 0.19 (0.49%)
NBP 53.60 Increased By ▲ 0.75 (1.42%)
OGDC 130.60 Decreased By ▼ -2.29 (-1.72%)
PAEL 25.36 Decreased By ▼ -0.29 (-1.13%)
PIBTL 6.25 Decreased By ▼ -0.13 (-2.04%)
PPL 118.90 Decreased By ▼ -0.60 (-0.5%)
PRL 23.95 Decreased By ▼ -0.65 (-2.64%)
PTC 12.92 Increased By ▲ 0.28 (2.22%)
SEARL 59.11 Decreased By ▼ -0.49 (-0.82%)
TELE 7.43 Decreased By ▼ -0.06 (-0.8%)
TOMCL 34.99 Decreased By ▼ -0.16 (-0.46%)
TPLP 8.72 Decreased By ▼ -0.13 (-1.47%)
TREET 15.90 Increased By ▲ 0.10 (0.63%)
TRG 55.95 Decreased By ▼ -1.95 (-3.37%)
UNITY 34.95 Increased By ▲ 0.06 (0.17%)
WTL 1.20 Decreased By ▼ -0.02 (-1.64%)
BR100 8,536 Decreased By -8.5 (-0.1%)
BR30 27,187 Decreased By -204 (-0.74%)
KSE100 79,944 Decreased By -48.3 (-0.06%)
KSE30 25,500 Decreased By -43.9 (-0.17%)
World

India approves Moderna's Covid-19 vaccine for emergency use

  • The vast nation of 1.3 billion people was hit by a massive spike in coronavirus cases in April and May that pushed the healthcare system to breaking point.
Published June 29, 2021

NEW DELHI: India on Tuesday authorised the emergency use of Moderna's Covid-19 vaccine as it seeks to ramp up its vaccination drive in the wake of a record-breaking surge in infections and deaths.

The vast nation of 1.3 billion people was hit by a massive spike in coronavirus cases in April and May that pushed the healthcare system to breaking point.

Moderna's shot is the fourth to be approved by New Delhi after Oxford-AstraZeneca's Covishield and Covaxin, which was developed by Indian firm Bharat Biotech, and Russia's Sputnik V.

"I am pleased to inform that an application received from Moderna through an Indian partner of theirs, Cipla, has been granted EUA (Emergency Use Authorisation)," a member of government advisory body NITI Aayog, Vinod K. Paul, said at a health ministry briefing.

"Our efforts to invite and to have other internationally developed vaccines, specifically Pfizer and J&J (Johnson & Johnson), also continue."

Paul added that the approval would pave the way for other foreign-made vaccines to be imported into India.

A small number of Sputnik V shots have imported into India after the drug was granted approval in mid-April, but the majority are expected to be manufactured within the country, like Covishield and Covaxin.

India said two months ago that it would fast-track the approval of vaccines manufactured outside the country that have already been granted emergency use authorisation by major regulators such as the US Food and Drug Administration.

The government had been under pressure to speed up its flagging inoculation drive by allowing the import of foreign-made vaccines such as mRNA vaccines Pfizer and Moderna.

Nearly 327 million doses have been administered since the mass vaccination programme kicked off in mid-January.

But just six percent of India's adult population -- or 57 million people -- have received both doses of a two-shot regime.

India is the world's second-most infected nation with more than 30 million cases and nearly 398,000 deaths.

Comments

Comments are closed.